نتائج البحث 81-90 من 9733 لعملية البحث عن Root%2Bcanal%2Btreatment
... treatment with carboplatin/vincristine (CV) in ... Targeted Therapy Directed by Genetic Testing in Treating ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة 44 ...
... 2 years post-registration to see if treatment is efficacious compared to historical data. Real-time Disease Monitoring of Metastatic Breast Cancer to ...
Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...
In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in combination with doxorubicin (Arm 2) ...
... 2 Dose (RP2D); and to evaluate the safety and ... treatment factors. A Study to Determine the ... The purpose of this study is to evaluate nab-paclitaxel as ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
... surgery (unresectable) and has come back (recurrent). IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases. Rochester, Minn. The purpose of ...
... treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). Cohort 2 includes (1) muCALR+ primary MF, and (2) muCALR+ secondary MF.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.